Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,650,000
-
Total 13F shares
-
133,950,846
-
Share change
-
-1,270,488
-
Total reported value
-
$3,522,042,268
-
Put/Call ratio
-
48%
-
Price per share
-
$26.28
-
Number of holders
-
262
-
Value change
-
-$34,152,841
-
Number of buys
-
116
-
Number of sells
-
124
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q3 2020
As of 30 Sep 2020,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
262 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,950,846 shares.
The largest 10 holders included
Artisan Partners Limited Partnership, BlackRock Inc., VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Bellevue Group AG, JPMORGAN CHASE & CO, STATE STREET CORP, Invesco Ltd., SNYDER CAPITAL MANAGEMENT L P, and Third Security, LLC.
This page lists
262
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.